Figure 4

![Figure 4: Summary of preclinical and clinical evidence for polyphenol-mediated gut microbiota remodeling in PCOS models. Specific bacterial genera (e.g., Lactobacillus, Bifidobacterium) enriched by polyphenol intake and their associated metabolic benefits are highlighted.]()

> Source: Ping Zhou et al. "Role of polyphenols in remodeling the host gut microbiota in polycystic ovary sy." *Journal of ovarian research*, 2024. PMID: [38539230](https://pubmed.ncbi.nlm.nih.gov/38539230/)

<figure>
  <img src="" alt="Summary of preclinical and clinical evidence for polyphenol-mediated gut microbiota remodeling in PCOS models. Specific bacterial genera (e.g., Lactobacillus, Bifidobacterium) enriched by polyphenol intake and their associated metabolic benefits are highlighted." />
  <figcaption>Figure 4. Summary of preclinical and clinical evidence for polyphenol-mediated gut microbiota remodeling in PCOS models. Specific bacterial genera (e.g., Lactobacillus, Bifidobacterium) enriched by polyphenol intake and their associated metabolic benefits are highlighted.<br>  Source: Ping Zhou et al. "Role of polyphenols in remodeling the host gut microbiota in polycystic ovary sy." <em>Journal of ovarian research</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38539230/">38539230</a></figcaption>
</figure>